• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
AI
{
  "authors": [
    "Mark Hibbs"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "NPP",
  "programs": [
    "Nuclear Policy"
  ],
  "projects": [],
  "regions": [
    "Middle East",
    "Iran"
  ],
  "topics": [
    "Nuclear Policy"
  ]
}

Source: Getty

In The Media

Is Iran a Ticking Time Bomb?

Although Iran has been making enriched uranium fuel, it is less clear if it is able to actually take nuclear material and make it into an explosive device.

Link Copied
By Mark Hibbs
Published on Oct 10, 2012

Source: Sun News

Speaking to Canada's Sun News, Carnegie's Mark Hibbs explained that if Iran wants a nuclear weapon, it has to do three things. First it has to make fissile material for a bomb; second, it has to make sure that the fissile material explodes exactly in the way they need it to do; and finally, Iran needs a delivery system to make the device an effective nuclear weapon.

"All these things are not trivial," Hibbs said, but "we know that Iran has been making the enriched uranium fuel, and they continue to do this." A report that came out this week speculates about how much of the needed fissile material Iran has, could make, and how it wants to use the material.

Hibbs pointed out, however, that it remains to be seen how much of the explosive work Iran can do or carry out to actually take nuclear material and make it into an explosive device. "It is a highly contentious issue," Hibbs said, adding "some evidence in the hands of the International Atomic Energy Agency explores this issue."

The concern for many people, Hibbs concluded, is the possibility that Iran still has undeclared, clandestine activities which no one knows about. "We don't really know much about what activities Iran has carried out outside of the declared activities." 

About the Author

Mark Hibbs

Nonresident Senior Fellow, Nuclear Policy Program

Hibbs is a Germany-based nonresident senior fellow in Carnegie’s Nuclear Policy Program. His areas of expertise are nuclear verification and safeguards, multilateral nuclear trade policy, international nuclear cooperation, and nonproliferation arrangements.

    Recent Work

  • Article
    Dimming Prospects for U.S.-Russia Nonproliferation Cooperation
      • Nicole Grajewski Profile Picture
      • +1

      Toby Dalton, Mark Hibbs, Nicole Grajewski, …

  • Commentary
    What Comes After Russia’s Attack on a Ukrainian Nuclear Power Station?

      Mark Hibbs

Mark Hibbs
Nonresident Senior Fellow, Nuclear Policy Program
Mark Hibbs
Nuclear PolicyMiddle EastIran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Article
    Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia

    An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.

      Gaddam Dharmendra

  • Commentary
    How WHO’s “One Health” Program Can Help India Tackle Monkeypox

    With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

      Shruti Sharma

  • Paper
    Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

    In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

      Shruti Sharma

  • Commentary
    Combating Vaccine Hesitancy in India

    Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

      Shruti Sharma

  • Commentary
    How Should Countries Study Viruses Safely?

    The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

      Shruti Sharma

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.